semaglutide nytimes Novo Nordisk's shortage officially concludes in the US, spelling major threat for weight loss drug compounders With Weight Loss Drugs, There's

doi: 10.1016/j.ijbiomac.2023.123234 61 HeYPengXLiuYWuQZhouQHuangYet al

Medical weight loss services are becoming a core part of aesthetic wellness offerings, and the newly-approved Wegovy pill will make it easier to integrate medical weight loss into your practice without the logistical complexity of injectables

And now that the semaglutide shortage is over, you may need to switch to FDA-approved versions anyway

Quick Answer: No GLP-1 patches are currently FDA-approved or commercially available in the United States for clinical use

95% CI: 6.76 to 88.48), followed by tirzepatide MTD (OR: 15.93

Hart AM, Wiberg M, Youle M, Terenghi G